Inspire Investing, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Inspire Investing, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$13.58 - $17.36 $26,942 - $34,442	-1,984 Reduced 7.29%	25,243 $397,000
Q4 2023 Feb 12, 2024	SELL	$10.11 - $16.54 $3,083 - $5,044	-305 Reduced 1.11%	27,227 $439,000
Q3 2023 Oct 26, 2023	BUY	$12.46 - $15.48 $32,184 - $39,984	2,583 Added 10.35%	27,532 $350,000
Q2 2023 Jul 31, 2023	BUY	$13.28 - $15.96 $66,147 - $79,496	4,981 Added 24.94%	24,949 $351,000
Q1 2023 Apr 24, 2023	BUY	$14.26 - $22.1 $78,130 - $121,085	5,479 Added 37.81%	19,968 $308,000
Q4 2022 Jan 26, 2023	BUY	$14.85 - $19.04 $49,019 - $62,851	3,301 Added 29.5%	14,489 $0
Q3 2022 Nov 07, 2022	BUY	$12.38 - $20.23 $138,507 - $226,333	11,188 New	11,188 $207,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.